GW Pharmaceuticals plc logo
GW Pharmaceuticals plc GWPH
$ 218.96 0.0%

GW Pharmaceuticals plc Retained Earnings 2011-2025 | GWPH

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings GW Pharmaceuticals plc

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-896 M -838 M -757 M -399 M -232 M -187 M -132 M -111 M -105 M -107 M
2020202020192019201820182017201720162016201520152014201420132013201220122011201100-200 M-200 M-400 M-400 M-600 M-600 M-800 M-800 M-1 B-1 B
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-105 M -896 M -376 M

Retained Earnings of other stocks in the Drug manufacturers industry

Issuer Retained Earnings Price % 24h Market Cap Country
Amryt Pharma plc Amryt Pharma plc
AMYT
-236 M $ 14.7 - $ 621 M britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
-1.15 B $ 15.25 - $ 754 M usaUSA
PetIQ PetIQ
PETQ
-161 M $ 13.6 1.64 % $ 400 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
-423 M $ 0.6 10.11 % $ 58.2 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
-121 M $ 0.173 -13.85 % $ 16.1 M usaUSA
Recro Pharma Recro Pharma
REPH
-279 M $ 1.4 -4.76 % $ 65.3 M usaUSA
Athenex Athenex
ATNX
-1.02 B $ 0.2 -23.39 % $ 1.76 M usaUSA
PLx Pharma PLx Pharma
PLXP
-148 M $ 0.09 -27.8 % $ 2.56 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
44.3 M $ 11.09 -3.90 % $ 97.2 M chinaChina
Organogenesis Holdings Organogenesis Holdings
ORGO
-40.1 M $ 3.96 -6.82 % $ 521 M usaUSA
Lannett Company Lannett Company
LCI
-596 M $ 0.66 1.15 % $ 7.11 M usaUSA
Perrigo Company plc Perrigo Company plc
PRGO
-2.25 B $ 20.5 -1.16 % $ 2.82 B usaUSA
ProPhase Labs ProPhase Labs
PRPH
11.8 M $ 0.32 -11.52 % $ 5.07 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
-1.43 B $ 40.0 -0.1 % $ 2.03 B schwedenSchweden
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
-505 M $ 8.22 - $ 376 M usaUSA
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
156 B $ 13.43 0.98 % $ 2.23 B indiaIndia
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
-782 M $ 9.12 - $ 459 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
12.3 M $ 4.5 1.35 % $ 17.8 M chinaChina
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
-245 M $ 9.25 0.11 % $ 419 M usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
556 M $ 56.0 1.57 % $ 3.09 B usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
-28 M $ 1.42 - $ 2.02 M chinaChina
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
-334 M $ 1.15 -2.54 % $ 57.2 M usaUSA
Endo International plc Endo International plc
ENDP
-15.4 B $ 0.29 - $ 28.9 M irlandaIrlanda
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
TEVA
-15.2 B $ 20.63 0.68 % $ 23.3 B israelIsrael
Tricida Tricida
TCDA
-810 M $ 0.11 - $ 3.25 M usaUSA
Tilray Tilray
TLRY
-2.42 B $ 1.31 -2.38 % $ 810 M canadaCanada
PPD, Inc. PPD, Inc.
PPD
-2.27 B $ 47.25 0.13 % $ 16.6 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
-9.78 B $ 6.87 -2.35 % $ 2.51 B canadaCanada
HEXO Corp. HEXO Corp.
HEXO
-659 M $ 0.71 2.45 % $ 38.1 M -
Veru Veru
VERU
-295 M $ 2.57 -12.88 % $ 347 M usaUSA
Neptune Wellness Solutions Neptune Wellness Solutions
NEPT
-164 M $ 0.2 -45.3 % $ 917 K canadaCanada
Viatris Viatris
VTRS
5.18 B $ 10.55 1.79 % $ 12.8 B usaUSA
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
2.39 B $ 42.97 - $ 1.62 B israelIsrael
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
590 M $ 116.3 - $ 26.6 B irlandaIrlanda
FSD Pharma FSD Pharma
HUGE
-90.9 M $ 5.84 5743.5 % $ 69.7 M canadaCanada
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
-305 M $ 0.78 0.86 % $ 117 M usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
-275 M $ 1.3 - $ 55.5 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-93.7 M $ 3.25 -0.31 % $ 3.64 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
-418 M $ 5.54 - $ 142 M usaUSA
Biogen Biogen
BIIB
19.3 B $ 152.15 -1.37 % $ 22.2 B usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
14.7 M $ 5.41 -6.08 % $ 184 M chinaChina
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
-607 M $ 5.91 2.6 % $ 892 M -
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
-1.7 B $ 1.88 -2.08 % $ 299 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
-794 M $ 18.86 -0.13 % $ 1.79 B franceFrance
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
-24 M $ 2.69 -9.17 % $ 37.8 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
-3.59 B $ 4.88 -1.41 % $ 86.3 M -
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
112 M $ 2.14 -39.89 % $ 27.7 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
-145 M $ 1.59 -2.16 % $ 402 M canadaCanada